StockData
InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc. (MTRI) stock

MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$17.50−2.37 (-11.93%)

Close on Nov 17, 2026Market cap $96.14MP/E –Yield –

InMed Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

InMed Pharmaceuticals's price to book ratio was 8.3× on Nov 3, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.1× to 8.3×, with a median of 0.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 3, 20268.3×+8.1
2025Dec 31, 20250.2×−0.1
2024Dec 31, 20240.4×+0.2
2023Oct 31, 20230.1×−0.0
2022Dec 30, 20220.2×−0.7
2021Dec 31, 20210.9×−2.9
2020Dec 31, 20203.8×–

More InMed Pharmaceuticals figures

See a number that looks wrong?